Skip to search formSkip to main contentSkip to account menu

Docetaxel-loaded Nanopharmaceutical CRLX301

Known as: CRLX301 
A nanoparticle-based formulation containing the poorly water-soluble, second-generation taxane analog docetaxel, with antineoplastic activity. Upon… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Cerulean Pharma Inc.9s Dynamic Tumor Targeting™ Platform creates nanoparticle-drug conjugates (NDCs) designed to significantly… 
2016
2016
2526Background: CRLX301 is an investigational NDC with DOC covalently conjugated to a cyclodextrin-polyethylene glycol co-polymer… 
2016
2016
Introduction. Nanoparticles (NPs) provide many advantages over small molecule drugs, such as greater solubility, increased… 
2012
2012
Docetaxel is one of the most commonly prescribed anticancer agents. While efficacious, the therapeutic benefits of docetaxel are…